By Daniel Akselrod · July 2026

Intake Forms for Endocrinology Practices: Hormone Symptoms, Lab History, and Multi-System Review

A referral arrives from primary care: a 47-year-old woman with fatigue, unexplained weight gain, and thinning hair. The referring physician checked a TSH, found it borderline, and sent her to endocrinology. By the time she reaches your office four weeks later, the clinical picture may involve not just the thyroid but also insulin resistance, vitamin D deficiency, perimenopausal hormone shifts, and early bone density loss. This is the fundamental challenge of endocrinology intake. The patient presents with one complaint, but the endocrine system does not operate in isolation. Hormones regulate metabolism, bone turnover, reproductive function, fluid balance, growth, and stress response simultaneously. The intake form that captures only the presenting complaint captures roughly twenty percent of what the endocrinologist needs to know.

The Endocrine Symptom Review: Crossing Organ-System Boundaries

Most specialty intake forms can focus their symptom review on a single organ system. A cardiology intake asks about chest pain, dyspnea, and palpitations. A gastroenterology intake asks about abdominal pain, bowel habits, and swallowing difficulty. Endocrinology does not have that luxury because hormonal dysfunction manifests across virtually every organ system, and patients rarely connect their constellation of symptoms to a single glandular problem. The woman with fatigue, weight gain, and hair thinning may also be experiencing constipation, dry skin, cold intolerance, joint stiffness, and heavy menstrual periods. Each of those symptoms individually could belong to a dozen different diagnoses. Together, they paint a picture of hypothyroidism that the endocrinologist recognizes instantly, but only if the intake form asked about all of them.

A structured endocrine symptom review needs to survey territory that no other specialty covers in a single form. Metabolic symptoms include unexplained weight changes in either direction, fatigue that does not improve with rest, and heat or cold intolerance. Dermatologic manifestations include hair loss or excessive hair growth, changes in skin texture or pigmentation, and easy bruising. Neuropsychiatric symptoms include anxiety, depression, cognitive fog, tremor, and sleep disturbance. Cardiovascular symptoms include palpitations, blood pressure changes, and exercise intolerance. Musculoskeletal symptoms include bone pain, muscle weakness, and cramping. Gastrointestinal symptoms include constipation, diarrhea, and changes in appetite. Genitourinary symptoms include excessive thirst, frequent urination, erectile dysfunction, and changes in libido. Reproductive symptoms include menstrual irregularities, infertility, galactorrhea, and hot flashes. The endocrinologist is not simply screening for these symptoms the way a primary care physician might. The endocrinologist is looking for patterns that cluster around specific glandular axes, and those patterns only emerge when the symptom review is broad enough to capture them.

Diabetes Management Documentation

Diabetes referrals account for a substantial portion of most endocrinology practices, and diabetes intake requires its own dedicated section that goes far beyond the single checkbox on a general medical history form. The intake must establish the type of diabetes, which is not always as straightforward as it sounds. A patient told they have type 2 diabetes at age 30 may actually have latent autoimmune diabetes of adults, a distinction with significant treatment implications. The form should capture the year of diagnosis, the circumstances of diagnosis (routine screening, symptomatic presentation, hospitalization for diabetic ketoacidosis), and any antibody testing that has been performed.

Current management documentation needs granularity that generic forms never provide. The intake should capture the complete medication regimen with dosages, including the specific insulin types and the number of units at each injection time for patients on insulin therapy. Oral and injectable non-insulin medications need their own fields because the sequence of medication trials and the reasons for discontinuation inform the endocrinologist's next therapeutic move. A patient who failed metformin due to gastrointestinal intolerance will be managed differently than one who failed it due to inadequate glycemic control. A patient already on maximum-dose combination therapy who is still running A1c values above nine percent is a different clinical problem than a newly diagnosed patient on metformin alone.

Hemoglobin A1c history over the past two to three years provides the trajectory that a single current value cannot. An A1c of 8.2 in a patient whose prior values were 7.0, 7.3, and 7.8 tells a story of progressive loss of glycemic control that demands investigation. The same A1c of 8.2 in a patient coming down from 12.4 six months ago tells a story of substantial improvement that warrants encouragement and continuation of the current approach. The intake form should capture at least the three most recent A1c values with their dates.

Hypoglycemic episodes are a critical safety concern that patients often underreport unless specifically asked. The form should ask about the frequency of low blood sugar episodes, whether the patient can always feel when blood sugar is dropping (hypoglycemic awareness), and whether any episodes required assistance from another person or emergency medical treatment. Severe hypoglycemia changes the glycemic targets and the treatment strategy fundamentally.

Complications screening documentation captures whether the patient is current on the surveillance that every diabetic patient requires. Retinal exams, comprehensive foot exams, urine microalbumin testing, and kidney function labs all operate on recommended screening intervals, and the endocrinologist needs to know whether those screenings are up to date and what they showed. A patient who has not had a dilated eye exam in four years needs an immediate referral regardless of whatever else the endocrinology visit addresses.

Thyroid History: More Than a TSH

Thyroid disorders are the other pillar of endocrinology practice, and thyroid intake requires a depth of history that the primary care referral rarely includes. The referring physician typically sends a TSH value and perhaps a free T4. The endocrinologist needs the complete thyroid narrative. Prior lab results should include not just TSH and free T4 but also free T3, thyroid antibodies (TPO and thyroglobulin antibodies), and thyroglobulin levels if thyroid cancer is in the differential. The form should capture whether these labs have been checked, when they were last obtained, and the results if the patient has them.

Thyroid imaging history matters because a patient who had a thyroid ultrasound showing a 1.2-centimeter nodule two years ago needs follow-up imaging to assess interval change. The intake form should ask whether the patient has had thyroid ultrasounds, how many, when the most recent was performed, and whether any nodules were identified. Fine-needle aspiration biopsy history is equally important: has one been performed, what was the cytology result, and was it classified using the Bethesda system. A patient with a prior biopsy showing atypia of undetermined significance is on a different surveillance pathway than a patient with a benign result.

Surgical and radiation history for the thyroid carries lifelong implications. Patients who have undergone thyroidectomy, whether partial or total, require ongoing thyroid hormone replacement monitoring. The intake should capture the type of surgery, the year, the indication (cancer, Graves disease, compressive goiter, cosmetic), and the pathology if known. Patients who received radioactive iodine therapy for Graves disease or thyroid cancer need documentation of the treatment date, the dose if recalled, and any post-treatment scanning results. Current thyroid medication should be recorded with the exact preparation (levothyroxine, liothyronine, desiccated thyroid, combination therapy), the dose, the time of day taken, and whether the patient has been consistent with dosing. The difference between a patient taking 100 micrograms of levothyroxine faithfully every morning on an empty stomach and a patient who takes the same dose sporadically with breakfast and calcium supplements is clinically significant even though the prescription is identical.

Bone Density and Calcium Metabolism

Metabolic bone disease intersects with nearly every other endocrine condition. Hyperthyroidism accelerates bone loss. Poorly controlled diabetes increases fracture risk through mechanisms that DEXA scanning may not fully capture. Vitamin D deficiency is endemic and affects calcium absorption, bone mineralization, and parathyroid hormone regulation. Glucocorticoid use, whether for adrenal insufficiency or prescribed by other specialists, is one of the most common causes of secondary osteoporosis. The endocrinology intake should capture DEXA scan results with the date, the T-scores at the spine and hip, and whether the patient has been diagnosed with osteopenia or osteoporosis. Fracture history is essential, particularly low-trauma fractures such as a wrist fracture from a standing-height fall or a vertebral compression fracture discovered incidentally on imaging.

Calcium and parathyroid hormone levels bridge the gap between bone health and broader endocrine evaluation. A patient referred for osteoporosis whose calcium is consistently elevated at 10.8 with a PTH of 95 does not simply have age-related bone loss. That patient has primary hyperparathyroidism, and the treatment is surgical, not pharmacologic. The intake form that captures calcium levels, PTH, and vitamin D alongside DEXA results gives the endocrinologist the complete metabolic bone picture before the patient enters the exam room. Current supplementation with calcium, vitamin D, and any osteoporosis medications (bisphosphonates, denosumab, teriparatide) should be documented with dosages and duration of use because treatment history constrains future management options.

Reproductive Endocrinology

The reproductive axis is one of the most frequent reasons for endocrinology referral, particularly in women of reproductive age, and the intake documentation needs to capture both the presenting concern and the broader hormonal context. Menstrual history should include the age of menarche, cycle regularity, the date of the last menstrual period, and any changes in cycle length or flow. Amenorrhea and oligomenorrhea have long differential diagnoses in endocrinology, spanning from polycystic ovary syndrome to hypothalamic dysfunction to prolactinoma to premature ovarian insufficiency, and the intake form needs to gather enough information for the endocrinologist to begin narrowing possibilities before the visit begins.

Polycystic ovary syndrome warrants its own intake subsection because it sits at the intersection of reproductive, metabolic, and dermatologic endocrinology. The form should capture symptoms of androgen excess, specifically acne distribution, hirsutism location and severity, and androgenic alopecia. Metabolic features of PCOS, including weight distribution, acanthosis nigricans, and difficulty losing weight despite dietary effort, inform whether the presentation leans toward the metabolic phenotype or the lean PCOS variant. Prior hormone testing, ovarian ultrasound results, and any treatments attempted, whether oral contraceptives, spironolactone, metformin, or letrozole for ovulation induction, all belong in the intake documentation.

Fertility concerns deserve explicit documentation because they change the treatment approach and the urgency. A patient with PCOS who is not seeking pregnancy can be managed with oral contraceptives and lifestyle modification. The same diagnosis in a patient who has been trying to conceive for fourteen months is a time-sensitive problem that may require ovulation induction, referral to reproductive endocrinology and infertility, or both. Hormone therapy documentation, whether oral contraceptives, hormone replacement therapy, testosterone replacement, or gender-affirming hormone therapy, should capture the specific preparation, the dose, the prescribing physician, and the duration of use.

Why Endocrinology Demands the Broadest Intake

The fundamental reason endocrinology intake is more complex than any other specialty intake is that no other organ system touches as many others. The thyroid affects heart rate, body temperature, bowel motility, bone density, menstrual regularity, cognitive function, and mood. Insulin resistance affects weight, cardiovascular risk, reproductive function, liver health, and skin. The adrenal glands regulate blood pressure, blood sugar, electrolyte balance, and the stress response. The pituitary gland governs growth, reproduction, thyroid function, adrenal function, and water balance from a single structure the size of a pea. When a patient presents to an endocrinologist, the clinical evaluation cannot be confined to the referring diagnosis. The patient sent for thyroid nodule evaluation may also need diabetes management, bone density assessment, and investigation of her irregular menstrual cycles. A single-system intake form forces the endocrinologist to discover these additional problems during the visit, consuming time that should be spent on assessment and management.

A well-designed endocrinology intake form functions as a multi-system screening instrument. It captures the presenting complaint in depth, surveys the full range of hormone-mediated symptoms, documents the management history of known endocrine conditions, records the laboratory and imaging data that the endocrinologist will need to interpret, and identifies the complications and comorbidities that every endocrine patient carries across organ-system boundaries. When that information arrives in the chart before the patient sits down, the endocrinologist can walk into the room with a provisional assessment already forming. When it does not, the visit becomes an extended interview that runs over time, delays subsequent patients, and still may not capture everything because a fifteen-minute conversation cannot substitute for a structured, comprehensive intake instrument designed for the complexity of endocrine medicine.

Endocrinology Intake Forms — $19.99 Complete Set

Intake form + client questionnaire. Fillable PDF. Instant download.

Browse Healthcare Forms

Not ready to buy? Download our free Universal Intake Form — a fillable PDF you can use today, no purchase needed.